These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 16168125
21. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer. Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH. Clin Cancer Res; 2006 Jan 15; 12(2):392-7. PubMed ID: 16428477 [Abstract] [Full Text] [Related]
22. Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes. Kadivar A, Kamalidehghan B, Akbari Javar H, Karimi B, Sedghi R, Noordin MI. Drug Des Devel Ther; 2017 Jan 15; 11():469-481. PubMed ID: 28260860 [Abstract] [Full Text] [Related]
27. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]. Zhang GH, Yang WT, Zhou XY, Zeng Y, Lu HF, Shi DR. Zhonghua Yi Xue Za Zhi; 2007 Jan 16; 87(3):155-60. PubMed ID: 17425844 [Abstract] [Full Text] [Related]
28. [Her-2 amplification and p185 expression in invasive breast cancer cells in women]. Titi S. Ann Acad Med Stetin; 2006 Jan 16; 52(2):5-12. PubMed ID: 17633393 [Abstract] [Full Text] [Related]
29. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling. Weigel MT, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Bauer M, Jonat W, Maass N, Mundhenke C. Cancer Lett; 2009 Jan 08; 273(1):70-9. PubMed ID: 18809244 [Abstract] [Full Text] [Related]
30. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome. Vestey SB, Perks CM, Sen C, Calder CJ, Holly JM, Winters ZE. Breast Cancer Res; 2005 Jan 08; 7(1):R119-29. PubMed ID: 15642160 [Abstract] [Full Text] [Related]
31. [Expression of platelet-derived growth factor receptor α and its ligand PDGF- A in breast cancer]. Liu DS, Zhang XJ, Chen G, Lu CF, Dong HY. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar 08; 27(3):313-4, 316. PubMed ID: 21638928 [Abstract] [Full Text] [Related]
32. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS. Anticancer Res; 2012 Mar 08; 32(3):923-37. PubMed ID: 22399613 [Abstract] [Full Text] [Related]
33. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy. Uehara G, Suzuki D, Toyoda M, Umezono T, Sakai H. Clin Exp Nephrol; 2004 Mar 08; 8(1):36-42. PubMed ID: 15067514 [Abstract] [Full Text] [Related]
34. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours? Liegl B, Leithner A, Bauernhofer T, Windhager R, Guelly C, Regauer S, Beham A. Histopathology; 2006 Dec 08; 49(6):576-81. PubMed ID: 17163842 [Abstract] [Full Text] [Related]
35. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Latta EK, Tjan S, Parkes RK, O'Malley FP. Mod Pathol; 2002 Dec 08; 15(12):1318-25. PubMed ID: 12481013 [Abstract] [Full Text] [Related]
36. Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations. Liegl B, Gülly C, Reich O, Nogales FF, Beham A, Regauer S. Histopathology; 2007 Mar 08; 50(4):448-52. PubMed ID: 17448020 [Abstract] [Full Text] [Related]
37. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Heldin CH, Wiestler OD, Louis DN, von Deimling A, Nistér M. Cancer Res; 1996 Jan 01; 56(1):164-71. PubMed ID: 8548759 [Abstract] [Full Text] [Related]
38. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR, Abd-Elwahed SR, Abdulwahed AR. Cell Biol Int; 2008 Jun 01; 32(6):698-707. PubMed ID: 18296077 [Abstract] [Full Text] [Related]
39. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S. Clin Cancer Res; 2006 Dec 01; 12(23):6920-8. PubMed ID: 17145809 [Abstract] [Full Text] [Related]
40. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Schirosi L, Lantuejoul S, Cavazza A, Murer B, Yves Brichon P, Migaldi M, Sartori G, Sgambato A, Rossi G. Am J Surg Pathol; 2008 Nov 01; 32(11):1627-42. PubMed ID: 18753943 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]